Please select the option that best describes you:
Topics:
Movement disorders
What is your view on the potential role of immune-targeted therapies in Parkinson’s disease?
In light of phase 2 data published on azathioprine for PD by Greenland et al in Lancet Neurol 2026 Jan
Answer from: at Community Practice
In my opinion, the role of immune-targeted therapies in Parkinson’s disease remains uncertain at this time.While both activated microglial cells and various cytokines associated with immune activation have been detected in Parkinson’s patients, it remains unclear whether these are pathologically...
Sign In or Register to read more